|

Asthma Clinical Trials in Dallas, TX

17 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 3<1 mi
Escitalopram in Asthma Patients With Frequent ExacerbationPhase 2<1 mi
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects—<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 3<1 mi
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPhase 3<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3<1 mi
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic AsthmaPhase 2<1 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)Phase 3<1 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 2<1 mi
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)Phase 3<1 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)—<1 mi
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) StudyN/A18 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 219 mi
Individualizing Treatment for Asthma in Primary Care (Full Study)Phase 431 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentPhase 331 mi
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in AdultsPhase 231 mi
Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyPhase 331 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.